Martha Goldberg Aronson - Aug 15, 2022 Form 4 Insider Report for Cardiovascular Systems Inc (CSII)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for Martha Goldberg Aronson pursuant to Power of Attorney previously filed.
Stock symbol
CSII
Transactions as of
Aug 15, 2022
Transactions value $
$0
Form type
4
Date filed
8/17/2022, 04:14 PM
Previous filing
Aug 9, 2022
Next filing
Apr 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSII Common Stock Options Exercise +2.41K +24.11% 12.4K Aug 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSII Restricted Stock Units Options Exercise $0 -2.41K -100% $0.00* 0 Aug 15, 2022 Common Stock 2.41K Direct F3
holding CSII Restricted Stock Units 20.8K Aug 15, 2022 Common Stock 20.8K Direct F2
holding CSII Restricted Stock Units 9.06K Aug 15, 2022 Common Stock 9.06K Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units were paid in shares of common stock on a one-for-one basis.
F2 Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
F3 Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment, and shall be payable in cash or shares of Company common stock on the payment date.
F4 Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 2,266 shares on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023.